Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000466839 | SCV000541765 | uncertain significance | Multiple endocrine neoplasia type 4 | 2024-02-01 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 11 of the CDKN1B protein (p.Pro11Ser). This variant is present in population databases (rs779193240, gnomAD 0.007%). This missense change has been observed in individual(s) with prostate cancer (PMID: 17372254). ClinVar contains an entry for this variant (Variation ID: 404268). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000567002 | SCV000673205 | likely benign | Hereditary cancer-predisposing syndrome | 2023-01-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV003128801 | SCV003805808 | uncertain significance | not provided | 2022-08-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with prostate cancer (Cybulski et al., 2007); This variant is associated with the following publications: (PMID: 17372254) |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153576 | SCV003843619 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000466839 | SCV005060218 | uncertain significance | Multiple endocrine neoplasia type 4 | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Zotz- |
RCV000466839 | SCV004041657 | uncertain significance | Multiple endocrine neoplasia type 4 | 2023-10-09 | no assertion criteria provided | clinical testing |